Drug Topics

APRIL 24, 2025

However, the results show that there was an improvement of symptom scores, although they were not significant.

341

341

STAT

APRIL 24, 2025

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be under threat from Health and Human Services Secretary Robert F. Kennedy Jr., a longtime vaccine critic. The “Vaccine Integrity Project,” which was publicly launched Thursday by the University of Minnesota’s Center for Infectious Disease Research and Policy, will be aimed at assessing the best ways for vaccine proponents to safeguard vaccination policy and

Vaccines 129

Vaccines 129

Drug Topics

APRIL 24, 2025

Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients use of OTC medications to treat pain.

315

315

STAT

APRIL 24, 2025

The federal health department is not creating a new registry of Americans with autism, a Department of Health and Human Services official said in a written statement Thursday. Instead, the official said, HHS will launch a $50 million research effort to understand the causes of autism spectrum disorder and improve treatments. The announcement arrives two days after National Institutes of Health Director Jay Bhattacharya announced the intent to create such a registry at an all staff meeting, kicki

Insurance 145

Insurance 145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

APRIL 24, 2025

A new AI-based company launched by the prolific venture capital firm Flagship Pioneering marks another platform approach in forward-thinking early science.

162

162

STAT

APRIL 24, 2025

The debate over the future of Medicaid continues to rage among Republicans. A House budget proposal released in February would slash up to $880 billion in spending over the next decade from the public health insurance program that 80 million low-income Americans rely on — including children, seniors, and people with disabilities.

Insurance 111

Insurance 111

STAT

APRIL 24, 2025

NASHVILLE, Tenn. — Robert F. Kennedy Jr.’s appearance at a major addiction and drug policy conference was marked by repeated interruptions on Thursday, as protesters and jeers forced him to pause and wait for noise to subside at least five times during his 36-minute speech.  A packed and deeply divided audience at the Rx and Illicit Drug Summit, taking place at a conference center on the city’s outskirts, applauded the health secretary as he entered and exited the stage

112

112

Hospital Pharmacy Europe

APRIL 24, 2025

The Medicines Optimisation Innovation Centre (MOIC) in Northern Ireland has become a pivotal force in advancing healthcare, particularly in the essential field of medicines optimisation. In this case study, marking a decade since its inception, Katherine Redpath examines MOICs achievements, ongoing projects and future aspirations. The suboptimal use of medicines presents a significant global challenge 1 , resulting in adverse health outcomes, inefficiencies and considerable waste.

Nursing Homes 59

Nursing Homes Hospitals Community Pharmacies Communication 59

STAT

APRIL 24, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I think I’ll go for a walk outside now The XBI is callin’ my name (I hear ya now) I just can’t stay uninvested all day I gotta get out get some of those bio-rays Biotechs are smilin’ Sunshine day Biotechs are laughin’ Sunshine day Every biotech seems so happy today It’

112

112

Pharmafile

APRIL 24, 2025

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse in paediatric acute lymphoblastic leukaemia (ALL), a common childhood cancer. Led by professor Persis Amrolia, a pioneer in CAR T-cell therapy at UCL and Great Ormond Street Hospital (GOSH), the trial intends to improve outcomes […] The post ViroCell and UCL launch trial to treat childhood leukaemia relapse appeared first on Pharmafile.

Hospitals 59

Hospitals 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

APRIL 24, 2025

How did Ireland become a hotspot for pharmaceutical manufacturing? What are the products that will come out of Flagship’s latest startup centered around “preemptive medicine”? And who among the co-hosts is the best singer? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.

72

72

Pharmafile

APRIL 24, 2025

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bios surveillance platform for hepatocellular carcinoma (HCC), a common form of liver disease. With its support, Mursla hopes to improve the effectiveness of early liver cancer detection. The FDAs BDD bolsters market access and commercial adoption by accelerating the […] The post Mursla Bios platform for surveillance of liver cancer receives FDA approval appeared first on Pharmaf

FDA 59

FDA 59

Hospital Pharmacy Europe

APRIL 24, 2025

Timing the use of a commonly prescribed asthma inhaler in the mid-afternoon could lead to improved clinical outcomes, according to new research led by the University of Manchester. The study, published in the journal Thorax , found that a once-daily dose of inhaled beclomethasone was most effective when taken between 3pm and 4pm. The findings suggest that aligning asthma medication with the bodys natural circadian rhythms could enhance its effectiveness without increasing the dose.

Hospitals 52

Hospitals Immunization 52

Pharmafile

APRIL 24, 2025

Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Rene Aguiar-Lucander, replacing Sren Tulstrup who led the company for seven years. Aguiar-Lucander has a wealth of experience in senior leadership positions in other biopharma companies, playing key roles in the growth and development of companies.

59

59

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

The Checkup by Singlecare

APRIL 24, 2025

Mounjaro (tirzepatide) is a prescription drug developed by Eli Lilly. It is approved by the Food and Drug Administration (FDA) for treating Type 2 diabetes. As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, it helps people manage their blood sugar levels. Because of its appetite-suppressing effects, its sometimes used for its weight-loss benefits.

Insurance 52

Insurance Customer Service Medication Guidelines Insurance Coverage 52

Pharmafile

APRIL 24, 2025

Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support the companys ambition to commercialise its leading therapy NUZ-001, a treatment for Amyotrophic lateral sclerosis (ALS) motor neurone disease. Kathryn Williams joins as chief regulatory officer (CRO).

59

59

The Checkup by Singlecare

APRIL 24, 2025

Actos is a brand-name medication that is approved by the Food and Drug Administration (FDA) to manage blood glucose (sugar) levels in adults with Type 2 diabetes mellitus. Also known by its generic name, pioglitazone, Actos is typically prescribed along with diet and exercise. Without insurance, the average retail price of Actos is $2,111 for 90, 30 mg tablets.

Insurance 52

Insurance Mail-Order Pharmacies Insurance Coverage Dosage 52

European Pharmaceutical Review

APRIL 24, 2025

Researchers have suggested a potential approach to measure the effective work of powder adhesion between particle-surface contact, using the drop test method. Specifically, they assessed irregularly shaped ibuprofen powders and spherical aluminium-alloy powders.Citing current adhesion challenges during tablet manufacturing, the authors highlighted the need to numerically predict if a new formulation may exhibit adhesion problems earlier [in R&D].

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

APRIL 24, 2025

Hypertension, more commonly referred to as high blood pressure, happens when blood pumps through the body too forcefully, which can cause damage to the blood vessels. When someone has hypertension, not only does their heart have to work harder, but it can also result in life-threatening conditions, like a heart attack or stroke. The potentially fatal condition is also extremely common, with the U.S.

52

52

STAT

APRIL 24, 2025

Caribou Biosciences is delaying the readout of clinical trials involving its CRISPR T-cell therapies for blood cancer — hoping that longer follow-up will deliver enough positive data to keep the programs and the struggling biotech company alive.  The company’s decision, announced Thursday, amounts to an all-or-nothing bet on the viability of two off-the-shelf CAR-T therapies that have, so far, failed to meet the high expectations set when Caribou emerged from the lab of CRISPR

60

60

pharmaphorum

APRIL 24, 2025

Meeting patients where they are: Improving bipolar I disorder care for Black Americans Nicole.

96

96

Pharmaceutical Technology

APRIL 24, 2025

Biogen Netherlands has received marketing authorisation from the UK MHRA for its Skyclarys to treat Friedreich's ataxia.

93

93

Fierce Healthcare

APRIL 24, 2025

State provider taxes are under the spotlight in Medicaid and soon could be the subject of a proposed rule by the Centers for Medicare & Medicaid Services.

90

90

pharmaphorum

APRIL 24, 2025

Roche is petitioning the US administration for an exemption from tariffs for pharmaceuticals, arguing there is no trade imbalance in its US business

89

89

Pharmacy Times

APRIL 24, 2025

The investigators hypothesis is supported by phase 2 trial data in which hydronidone resulted in significant reversal of liver fibrosis in patients with chronic hepatitis B (CHB).

81

81

pharmaphorum

APRIL 24, 2025

A five-year genomics study that aims to transform the care of children with cancer and improve treatment success has launched in Ireland

86

86

Fierce Healthcare

APRIL 24, 2025

The healthcare industry remains a favorite target of attackers, and there was an uptick in both incidents and data breaches in 2024. System intrusion, which includes ransomware, is now the top cause of healthcare data breaches, a Verizon report found.

78

78

Pharmacy Times

APRIL 24, 2025

Because mothers are already at risk of depression postpartum, health care professionals must properly counsel mothers on hormonal contraceptives.

73

73

pharmaphorum

APRIL 24, 2025

AstraZeneca has started work with Tempus and Pathos AI on a $200m project to build a comprehensive multimodal foundation model for oncology

72

72

Pharmacy Times

APRIL 24, 2025

A study reveals IVIG treatment shows no significant benefits over tocilizumab for severe COVID-19, highlighting higher adverse events and costs.

73

73

pharmaphorum

APRIL 24, 2025

There is currently no approved treatment for intracerebral haemorrhagic stroke, but Belgian startup Bioxodes hopes to change that

69

69

Fierce Healthcare

APRIL 24, 2025

An investigative report released Thursday by a leading healthcare policy legislator was partially contested by 340B hospitals but hailed by the drug manufacturer lobby.

Hospitals 67

Hospitals 67

pharmaphorum

APRIL 24, 2025

Women are being overlooked in the UK's HIV response and can face barriers to accessing prevention, testing, and care, says a new campaign.

66

66